[
  {
    "ts": "2025-12-23T11:19:48+00:00",
    "headline": "Abbott Wins FDA Clearance for Volt",
    "summary": "New heart device targets atrial fibrillation",
    "url": "https://finance.yahoo.com/news/abbott-wins-fda-clearance-volt-111948093.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "c6bd0bce-c51d-355c-85f9-1b39d7ffe9fd",
      "content": {
        "id": "c6bd0bce-c51d-355c-85f9-1b39d7ffe9fd",
        "contentType": "STORY",
        "title": "Abbott Wins FDA Clearance for Volt",
        "description": "",
        "summary": "New heart device targets atrial fibrillation",
        "pubDate": "2025-12-23T11:19:48Z",
        "displayTime": "2025-12-23T11:19:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/4db795aedb685021fe0dc344f8ccfc7a",
          "originalWidth": 416,
          "originalHeight": 416,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C6yONRHLZhlWoNeIb3coEg--~B/aD00MTY7dz00MTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/4db795aedb685021fe0dc344f8ccfc7a.cf.webp",
              "width": 416,
              "height": 416,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/axtwgvFMo1V9vEkaNtLlJw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/4db795aedb685021fe0dc344f8ccfc7a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-wins-fda-clearance-volt-111948093.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-wins-fda-clearance-volt-111948093.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:20:00+00:00",
    "headline": "Should You Hold On To BSX Stock Despite Its Premium Valuation?",
    "summary": "Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.",
    "url": "https://finance.yahoo.com/news/hold-bsx-stock-despite-premium-122000453.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8435fa37-6ced-3408-a5bf-6c2ca8f68c47",
      "content": {
        "id": "8435fa37-6ced-3408-a5bf-6c2ca8f68c47",
        "contentType": "STORY",
        "title": "Should You Hold On To BSX Stock Despite Its Premium Valuation?",
        "description": "",
        "summary": "Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.",
        "pubDate": "2025-12-23T12:20:00Z",
        "displayTime": "2025-12-23T12:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hold-bsx-stock-despite-premium-122000453.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hold-bsx-stock-despite-premium-122000453.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]